Published

Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The Journal of clinical psychiatry
Date: 2025-03-03
Source: PubMed
DOI: 10.4088/jcp.24m15449
PubMed: 40047545

Authors

Goodwin GM Nowakowska A Atli M Dunlop BW Feifel D Hellerstein DJ Marwood L Shabir Z Mistry S Stansfield SC Teoh E Tsai J Young MB Malievskaia E

Watch author

Derived topics and classifications

psilocybin Depression Mechanism of Action Observational Study Treatment-Resistant Depression Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 6 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01 Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27 Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15 Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.2025-03-03

Related papers

Characterization of Altered Waking States of Consciousness in Healthy HumansClinicalTrials.gov · 2021-04-29